In Vivo Fluorescence-Based Endoscopic Detection of Colon Dysplasia in the Mouse Using a Novel Peptide Probe

Colorectal cancer (CRC) is a major cause of cancer-related deaths in much of the world. Most CRCs arise from pre-malignant (dysplastic) lesions, such as adenomatous polyps, and current endoscopic screening approaches with white light do not detect all dysplastic lesions. Thus, new strategies to identify such lesions, including non-polypoid lesions, are needed. We aim to identify and validate novel peptides that specifically target dysplastic colonic epithelium in vivo. We used phage display to identify a novel peptide that binds to dysplastic colonic mucosa in vivo in a genetically engineered mouse model of colo-rectal tumorigenesis, based on somatic Apc (adenomatous polyposis coli) gene inactivation. Binding was confirmed using confocal microscopy on biopsied adenomas and excised adenomas incubated with peptide ex vivo. Studies of mice where a mutant Kras allele was somatically activated in the colon to generate hyperplastic epithelium were also performed for comparison. Several rounds of in vivo T7 library biopanning isolated a peptide, QPIHPNNM. The fluorescent-labeled peptide bound to dysplastic lesions on endoscopic analysis. Quantitative assessment revealed the fluorescent-labeled peptide (target/background: 2.17±0.61) binds ∼2-fold greater to the colonic adenomas when compared to the control peptide (target/background: 1.14±0.15), p<0.01. The peptide did not bind to the non-dysplastic (hyperplastic) epithelium of the Kras mice. This work is first to image fluorescence-labeled peptide binding in vivo that is specific towards colonic dysplasia on wide-area surveillance. This finding highlights an innovative strategy for targeted detection to localize pre-malignant lesions that can be generalized to the epithelium of hollow organs.

[1]  S. Shirasawa,et al.  Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. , 1993, Science.

[2]  J. Wolff,et al.  In Vivo Selection and Validation of Liver-Specific Ligands Using a New T7 Phage Peptide Display System , 2007, Drug delivery.

[3]  Erkki Ruoslahti,et al.  Targeting the prostate for destruction through a vascular address , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Zhiyuan Hu,et al.  Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library , 2007, Journal of biomolecular screening.

[5]  Ralph Weissleder,et al.  Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. , 2007, Radiology.

[6]  M F Dixon,et al.  Flat adenomas in the United Kingdom: are treatable cancers being missed? , 1998, Endoscopy.

[7]  E Ruoslahti,et al.  Vascular homing peptides with cell-penetrating properties. , 2005, Current pharmaceutical design.

[8]  J. Scott,et al.  Searching for peptide ligands with an epitope library. , 1990, Science.

[9]  G. Walkup,et al.  Fluorescent chemosensors for divalent zinc based on zinc finger domains. Enhanced oxidative stability, metal binding affinity, and structural and functional characterization , 1997 .

[10]  P. Bossuyt,et al.  Polyp Miss Rate Determined by Tandem Colonoscopy: A Systematic Review , 2006, The American Journal of Gastroenterology.

[11]  A. Sweet-Cordero,et al.  Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon , 2008, Nature Genetics.

[12]  Juyoung Yoon,et al.  Design, synthesis, and evaluation of peptidyl fluorescent probe for Zn2+ in aqueous solution. , 2007, Bioorganic & medicinal chemistry letters.

[13]  J. Jass.  Classification of colorectal cancer based on correlation of clinical, morphological and molecular features , 2007, Histopathology.

[14]  B. Leggett,et al.  Role of the serrated pathway in colorectal cancer pathogenesis. , 2010, Gastroenterology.

[15]  E. Ruoslahti,et al.  Molecular specialization of breast vasculature: A breast-homing phage-displayed peptide binds to aminopeptidase P in breast vasculature , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Zauber,et al.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .

[17]  Hung-Yun Lin,et al.  Integrin αVβ3 contains a receptor site for resveratrol , 2006 .

[18]  Lee Makowski,et al.  RELIC – A bioinformatics server for combinatorial peptide analysis and identification of protein‐ligand interaction sites , 2004, Proteomics.

[19]  Steven Brown,et al.  A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom , 2003, American Journal of Gastroenterology.

[20]  Ralph Weissleder,et al.  In vivo imaging of molecularly targeted phage. , 2006, Neoplasia.

[21]  D. Hanahan,et al.  Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis. , 2003, Cancer cell.

[22]  Ralph Weissleder,et al.  In vivo selection of phage for the optical imaging of PC-3 human prostate carcinoma in mice. , 2006, Neoplasia.

[23]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[24]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[25]  E. Fearon,et al.  Generating somatic mosaicism with a Cre recombinase–microsatellite sequence transgene , 2008, Nature Methods.

[26]  Umar Mahmood,et al.  Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment , 2010, Proceedings of the National Academy of Sciences.

[27]  M. Neurath,et al.  High resolution colonoscopy in live mice , 2006, Nature Protocols.

[28]  C. Bacchi,et al.  Flat elevated lesions of the colon and rectum: a spectrum of neoplastic and nonneoplastic entities. , 2006, Annals of diagnostic pathology.

[29]  Stephen Albert Johnston,et al.  In vitro selection of a peptide with high selectivity for cardiomyocytes in vivo. , 2004, Journal of molecular biology.

[30]  S. Deutscher,et al.  Biodistribution of filamentous phage peptide libraries in mice , 2004, Molecular Biology Reports.

[31]  David A Jones,et al.  Isolation of a colon tumor specific binding peptide using phage display selection. , 2003, Neoplasia.

[32]  Kathleen R. Cho,et al.  Mouse model of colonic adenoma-carcinoma progression based on somatic Apc inactivation. , 2007, Cancer research.

[33]  Nina M. Muñoz,et al.  TGF-beta receptor inactivation and mutant Kras induce intestinal neoplasms in mice via a beta-catenin-independent pathway. , 2009, Gastroenterology.

[34]  Marie Evangelista,et al.  The Hedgehog Signaling Pathway in Cancer , 2006, Clinical Cancer Research.

[35]  Christopher H Contag,et al.  Detection of colonic dysplasia in vivo using a targeted heptapeptide and confocal microendoscopy. , 2008, Nature medicine.

[36]  Erkki Ruoslahti,et al.  Organ targeting In vivo using phage display peptide libraries , 1996, Nature.

[37]  Hung-Yun Lin,et al.  Integrin alphaVbeta3 contains a receptor site for resveratrol. , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  B. Kay,et al.  Convergent evolution with combinatorial peptides , 2000, FEBS letters.

[39]  R. Barrett,et al.  Peptides on phage: a vast library of peptides for identifying ligands. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  H. Godwin,et al.  A Selective, Ratiometric Fluorescent Sensor for Pb2+ , 2000 .

[41]  K. Schughart,et al.  Tumor cell-targeting by phage-displayed peptides , 2002, Cancer Gene Therapy.

[42]  Erkki Ruoslahti,et al.  Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display , 2007, Molecular Cancer Research.

[43]  J. Lewis,et al.  Colonic dysplasia and cancer in inflammatory bowel disease. , 2002, Gastrointestinal endoscopy clinics of North America.

[44]  Benjamin Bolduc,et al.  A target-unrelated peptide in an M13 phage display library traced to an advantageous mutation in the gene II ribosome-binding site. , 2008, Analytical biochemistry.

[45]  Lee Makowski,et al.  T7 lytic phage‐displayed peptide libraries exhibit less sequence bias than M13 filamentous phage‐displayed peptide libraries , 2006, Proteomics.

[46]  H. Blum,et al.  Molecular pathogenesis of colorectal cancer , 2005, Cancer.

[47]  J F Mayberry,et al.  Flat adenomas exist in asymptomatic people: important implications for colorectal cancer screening programmes , 1998, Gut.

[48]  G. Fields,et al.  Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. , 2009, International journal of peptide and protein research.

[49]  Toyoaki Tenzen,et al.  The cell surface membrane proteins Cdo and Boc are components and targets of the Hedgehog signaling pathway and feedback network in mice. , 2006, Developmental cell.

[50]  Thomas D. Wang,et al.  Affinity peptide for targeted detection of dysplasia in Barrett's esophagus. , 2010, Gastroenterology.

[51]  P. Troncoso,et al.  Combinatorial Screenings in Patients , 2004, Cancer Research.